Universitätsklinikum Gießen und Marburg

What Universitätsklinikum Gießen und Marburg does

Universitätsklinikum Gießen und Marburg (UKGM) is a two-campus German university hospital formed in 2005 from the merger of the university hospitals in Gießen and Marburg and taken over by RHÖN-KLINIKUM AG in 2006, making it the only university hospital in Germany under near-complete private ownership. The hospital delivers Maximalversorgung (maximum-care) services across more than 80 specialized clinics and institutes at its Gießen (Rudolf-Buchheim-Straße) and Marburg (Lahnberge/Baldingerstraße) campuses, treating approximately 500,000 patients per year (~400,000 outpatient and ~100,000 inpatient). It is structured as Universitätsklinikum Gießen und Marburg GmbH with a wholly-owned subsidiary MVZ UKGM GmbH for outpatient medical care, and is clinically and academically integrated with Justus-Liebig-Universität Gießen and Philipps-Universität Marburg through co-located medical faculties and shared governance.

The hospital's product surface spans robotic-assisted surgery (Da Vinci XI at both locations for urology, gynecology, and general surgery), advanced laboratory diagnostics (4 million analyses/year at Marburg alone), a Comprehensive Cancer Center (CCC Marburg), a Children's Heart Center, a Transplant Center, specialized centers for diabetes, obesity, cochlear implants, and rare diseases, and a blood transfusion service that collects ~37,000 units/year against demand of ~50,000. The IKI.med Institute (founded 2020 jointly with Philipps-Universität Marburg) drives AI-in-medicine research including decision support (Ada DX), predictive analytics, and biopsychosocial digital health representations, with the Münch Foundation providing funding. Underlying IT infrastructure includes Orbis EMR, Lauris laboratory information systems, and the GIFONET research network, with publicly visible digital tools such as the Körperkompass (Body Compass) symptom navigation interface.

UKGM's revenue model rests on statutory and private health insurance reimbursement for inpatient and outpatient services billed under Germany's G-DRG system and the GOÄ fee schedule for private patients, supplemented by teaching and research funding channeled through its university partners, and by production of blood components. It maintains a vendor base of approximately 2,500 suppliers, supports 1,400 training positions, and operates an MVZ for outpatient services and a dedicated International Patients division. The hospital's ownership by RHÖN-KLINIKUM AG, combined with Asklepios executives on its Supervisory Board, ties its governance to a broader private hospital group whose network members (Campus Bad Neustadt, Klinikum Frankfurt (Oder), Zentralklinik Bad Berka) enable group-level knowledge transfer and laboratory consolidation through Medilys.

Name

Universitätsklinikum Gießen und Marburg

Legal name

Universitätsklinikum Gießen und Marburg GmbH

Website

https://ukgm.de

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

German university hospital operating two campuses (Gießen and Marburg) that provides maximum-care medical services across 80+ clinics and institutes to approximately 500,000 patients annually, integrating clinical care, research, and medical education under near-complete private ownership by RHÖN-KLINIKUM AG.

Ownership category

akta.pro rank

Product category

University Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221), Offices of Physicians (62111)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA)

Keywords

• University hospital services
• Maximum care medicine
• Oncology and transplantation
• Robotic assisted surgery
• Medical research and teaching

Headquarters

HQ city

Marburg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Services (Statutory and Private Health Insurance): UKGM generates revenue primarily through billing for medical services provided to inpatients and outpatients, reimbursed through Germany's statutory health insurance (GKV) system and private health insurance. This is the dominant revenue stream for the hospital.
2. Teaching and Research Funding: As a university hospital, UKGM receives funding and support for medical education and research activities from the Justus-Liebig-Universität Gießen and Philipps-Universität Marburg. Research collaborations and grants contribute to the institution's financial ecosystem.
3. Blood Products and Transfusion Services: The hospital's blood transfusion center collects approximately 37,000 blood units annually, producing blood products for internal use and contributing to regional blood supply. Revenue is derived from the production and provision of blood components to patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Universitätsklinikum Gießen und Marburg operates a dual-campus university hospital providing Maximalversorgung (maximum-care) medical services through more than 80 specialized clinics and institutes at Gießen and Marburg, treating roughly 500,000 inpatients and outpatients per year. Services include robotic-assisted surgery (Da Vinci XI), comprehensive oncology (CCC Marburg and UCT Frankfurt-Marburg), organ and stem cell transplantation, pediatric cardiology, cochlear implantation, obesity and diabetes care, advanced laboratory medicine and pathology, plus medical teaching and translational research in partnership with Justus-Liebig-Universität Gießen and Philipps-Universität Marburg.

Product overview

Universitätsklinikum Gießen und Marburg (UKGM) is a dual-location university hospital offering comprehensive medical services through more than 80 clinics and institutes. The organization operates as a unified hospital system at two campuses (Gießen and Marburg), providing maximum care (Maximalversorgung) for over 500,000 patients annually. Key offerings include robotic-assisted surgery (DaVinci Vinci-XI), specialized centers (Comprehensive Cancer Center, AI in Medicine Institute, Children's Heart Center, Transplant Center), advanced diagnostic services (laboratory medicine, pathology, virology, microbiology), and digital health tools. The hospital serves as a teaching institution affiliated with Justus-Liebig-Universität Gießen and Philipps-Universität Marburg, combined with research and patient care functions.

Differentiator

Problem solved

Functional benefit

Products and services

• Robot-assisted surgery with Da Vinci XI system Robot-assisted surgical services using the Da Vinci XI system available at both UKGM campuses for urology, gynecology, and general surgery procedures, for patients requiring minimally invasive complex surgery.
• Institute for Artificial Intelligence in Medicine (IKI.med) Interdisciplinary joint institute of Philipps-Universität Marburg and UKGM, established in 2020, focused on AI-driven medical decision support, holistic digital health representation, and digital guidance systems for citizens in health-uncertain situations.
• Universitäres Adipositaszentrum Mittelhessen Specialized obesity treatment center offering comprehensive multidisciplinary care for patients with obesity and related conditions.
• Cochlear Implant Centrum Mittelhessen Specialized hearing restoration center providing cochlear implant services for deaf and hard-of-hearing patients, with provisional certification by the Deutsche Gesellschaft für Hals-Nasen-und Ohrenheilkunde.
• Universitäres Diabeteszentrum Mittelhessen Specialized diabetes treatment center providing comprehensive diabetes care and management.
• Comprehensive Cancer Center Marburg Comprehensive cancer center with multiple DKG-certified tumor centers (breast, gynecologic, lung, prostate, head/neck, neuro-oncology, leukemia/lymphoma, skin, visceral oncology) and the Carreras Leukemia Center, certified by Deutsche Krebsgesellschaft and partner in the UCT Frankfurt-Marburg Oncology Center of Excellence.
• Kinderherzzentrum (Children's Heart Center) Specialized pediatric cardiology and cardiac surgery center treating congenital and acquired heart conditions in children.
• Transplantationszentrum (Transplantation Center) Organ transplantation center performing kidney, liver, and other organ transplants, plus JACIE-accredited autologous and allogeneic stem cell transplantation.
• Zentrum für seltene Erkrankungen Gießen (Center for Rare Diseases) Center dedicated to multidisciplinary diagnosis and treatment of rare diseases, supporting complex cases requiring subspecialty expertise.
• Respiratorisches Virusbarometer (Respiratory Virus Barometer) Weekly PCR-based monitoring service tracking the spread of SARS-CoV-2, influenza, and RSV at UKGM Marburg, providing public visibility into respiratory infection trends based on first detections in a one-year period.
• Körperkompass (Body Compass) Interactive digital navigation tool allowing patients to identify and connect with the right specialist and clinic for their symptoms by interacting with a body graphic, linking body regions to relevant UKGM treatment departments.
• Blutspendedienst (Blood Donation Service) Blood donation and transfusion service collecting approximately 37,000 blood units per year to meet the hospital's annual demand of about 50,000 units; produces blood products for patient care and contributes to regional blood supply.

Quantifiable outcome

• 3rd largest university hospital in Germany by patient volume
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Institute for Artificial Intelligence in Medicine (IKI.med) - Joint InstitutioncoreStrategic or Co-development Partner · 1 January 2020IKI.med was founded in 2020 as a joint institution of Philipps-Universität Marburg and UKGM, with the goal of researching and actively shaping the digital transformation in healthcare. It is the first of several institutes forming the Center for Digital Medicine at the intersection of Medicine and Computer Science faculties.
• Justus-Liebig-Universität Gießen (JLU Gießen) / Fachbereich 11 MedizincoreStrategic or Co-development Partner · 1 January 2005JLU Gießen and its Faculty of Medicine (FB 11) collaborate with UKGM on medical research and teaching. Research and teaching are governed by detailed contractual agreements between the university and UKGM. The university provides academic leadership through the Dean, while UKGM provides clinical infrastructure. The hospital bears the university's logo alongside its own.
• Philipps-Universität Marburg / Fachbereich 20 MedizincoreStrategic or Co-development Partner · 1 January 2005Philipps-Universität Marburg and its Faculty of Medicine (FB 20) collaborate with UKGM on medical research and teaching. The university's Department of Human Genetics, AI Institute, and other academic units are co-located or closely integrated with UKGM Marburg. The Dean (Prof. Dr. Michael Hertl) participates in UKGM's Extended Executive Board.
• Universitäres Cancer Center (UCT) Frankfurt-MarburgcoreStrategic or Co-development PartnerA joint oncology center between UKGM Marburg and University Hospital Frankfurt, designated as an 'Oncology Center of Excellence' by Deutsche Krebshilfe. The partnership integrates cancer care, research, and teaching across both institutions, with UKGM's Comprehensive Cancer Center Marburg serving as a key partner.
• Comprehensive Cancer Center (CCC) MarburgcoreStrategic or Co-development PartnerCCC Marburg is a comprehensive cancer center at UKGM Marburg that encompasses multiple certified tumor centers (breast, gynecologic, head/neck, lung, lymphoma/leukemia, neuro-oncology, prostate, skin, visceral oncology, and others). It is externally verified by Deutsche Krebsgesellschaft (DKG) through OnkoZert.
• Verbundkliniken RHÖN-KLINIKUM AG (Campus Bad Neustadt, Klinikum Frankfurt (Oder), Zentralklinik Bad Berka)minorChannel Partner/ Reseller/ DistributorUKGM is part of the RHÖN-KLINIKUM AG hospital network, which includes Campus Bad Neustadt a.d. Saale, Klinikum Frankfurt (Oder), and Zentralklinik Bad Berka. These network hospitals collaborate through knowledge sharing, best practice exchange, and patient referral pathways within the same parent company.
• Asklepios Kliniken GmbH & Co. KGaAminorStrategic or Co-development PartnerAsklepios Kliniken GmbH & Co. KGaA is represented on UKGM's Supervisory Board and drives centralization processes in collaboration with laboratory networks such as Medilys in Hamburg. Multiple Asklepios executives serve on UKGM's Supervisory Board (Marco Walker - CEO, PD Dr. Sara Sheikhzadeh - CMO, Dr. Cornelia Süfke - General Counsel), indicating shared governance through the common parentage of RHÖN-KLINIKUM AG's majority shareholder.
• Laborverbund Medilys (Hamburg)minorChannel Partner/ Reseller/ DistributorMedilys laboratory network in Hamburg collaborates with UKGM within the Asklepios group for centralization of specialized diagnostics, including therapeutic drug monitoring, immunology, allergology, metabolic diagnostics, autoimmun diagnostics, and toxicology.
• VASCERN (European Reference Network for Rare Vascular Diseases)minorStrategic or Co-development PartnerThe Angioma Center Marburg at UKGM is a Full Member of VASCERN, the European Reference Network for Rare Vascular Diseases, as designated by the European Commission. This membership enables cross-border collaboration on rare vascular disease diagnosis and treatment.
• HHT Foundation International / CureHHTminorStrategic or Co-development PartnerUKGM's Clinic for Ear, Nose and Throat Medicine is designated as an International HHT (Hereditary Hemorrhagic Telangiectasia) Treatment Center through the HHT Foundation International/CureHHT, providing specialized care for this rare genetic condition.
• Verband der Universitätsklinika Deutschlands (VUD)minorStrategic or Co-development PartnerUKGM participates in the 'Wir sind Vielfalt' (We Are Diversity) campaign organized by VUD (the Association of German University Hospitals), representing 34 university hospitals and over 190,000 employees advocating for diversity, tolerance, and openness in healthcare, research, and education.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Charité – Universitätsmedizin Berlin: Europe's largest university hospital and Germany's most prominent public Maximalversorgung provider with ~100 clinics and institutes across four campuses. Directly comparable as a full-service university hospital with research/teaching mission, oncology center of excellence, and similar specialty breadth (transplant, rare disease, robotic surgery).
• Universitätsklinikum Heidelberg: One of Germany's largest university hospitals with comprehensive Maximalversorgung across all major specialties, National Center for Tumor Diseases (NCT), and major research/teaching mission. Comparable scale, specialty coverage, and academic integration; publicly owned, contrasting UKGM's private model.
• Klinikum der Universität München (LMU Klinikum): Major German public university hospital providing maximum care across two campuses (Großhadern and Innenstadt) with comparable patient volumes and specialty breadth. Both serve as academic teaching hospitals and oncology/transplant centers of reference.
• Universitätsklinikum Hamburg-Eppendorf (UKE): Hamburg's university hospital with comparable specialty breadth, research intensity, and Maximalversorgung mandate. Comparable in scale (~1,500+ beds, multiple specialty centers) and operates with similar university partnership structure, though publicly owned.
• Universitätsklinikum Frankfurt: Partner of UKGM in the joint UCT Frankfurt-Marburg oncology center, providing Maximalversorgung with similar specialty profile and academic mission. Direct peer through the formal UCT partnership, both serving Hesse region's tertiary/quaternary care needs.
• Universitätsklinikum Essen: German university hospital providing maximum care across West Germany, with comparable Westdeutsches Tumorzentrum (WTZ) oncology designation and similar specialty center structure. Comparable scale and academic integration.
• Universitätsklinikum Tübingen: South German university hospital with comparable research intensity, Maximalversorgung profile, and oncology/transplant center of excellence designation. Similar specialty breadth and academic-medical structure.

Broad incumbents

• Helios Kliniken: Germany's largest private hospital operator (owned by Fresenius) with 80+ hospitals nationwide. Compares as a broader private-sector incumbent running both university and non-university hospitals; shares private-sector efficiency orientation but operates at much larger aggregate scale than UKGM alone.
• Asklepios Kliniken: Major German private hospital chain and majority owner of RHÖN-KLINIKUM AG (UKGM's parent). Directly comparable through governance overlap, private hospital operations, and shared Medilys laboratory network; operates at broader portfolio level rather than UKGM's university-hospital specialty.
• Sana Kliniken: German private hospital group operating 50+ facilities, including university-related hospitals. Comparable as a private-sector hospital operator with academic affiliations and similar German GKV/DRG reimbursement model exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/ukgm_presse
• Facebookfacebook.com/profile.php

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Universitätsklinikum Gießen und Marburg